Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population

Rheumatology (United Kingdom)

Volumn 54, Issue 7, 2015, Pages 1262-1269

  Hachulla, Eric ^a   Clerson, Pierre ^b   Airò, Paolo ^c   Cuomo, Giovanna ^d   Allanore, Yannick ^e   Caramaschi, Paola ^f   Rosato, Edoardo ^g   Carreira, Patricia E ^h   Riccieri, Valeria ^g   Sarraco, Marta ⁱ   Denton, Christopher P ^j   Riemekasten, Gabriela ^k,l   Pozzi, Maria Rosa ^m   Zeni, Silvana ⁿ   Mihai, Carmen Marina ^o   Ullman, Susanne ^p   Distler, Oliver ^q   Rednic, Simona ^r   Smith, Vanessa ^s   Walker, Ulrich A ^t   Matucci Cerinic, Marco ^u   Müller Ladner, Ulf ^v   Launay, David ^a   more..

^a UNIV LILLE   (France)

^b Orgamètrie biostatistiques   (France)

^c SPEDALI CIVILI   (Italy)

^d FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY HOSPITAL OF VERONA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

ⁱ MAURIZIANO HOSPITAL   (Italy)

^j ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l A Leibniz Institute   (Germany)

^m SAN GERARDO HOSPITAL   (Italy)

ⁿ UNIVERSITY OF MILAN   (Italy)

^o Ion Cantacuzino Clinical Hospital   (Romania)

^p Mental Health Center Glostrup   (Denmark)

^q UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^r IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^s GHENT UNIVERSITY HOSPITAL   (Belgium)

^t Felix Platter Spital   (Switzerland)

^u UNIVERSITY OF FLORENCE   (Italy)

^v JUSTUS LIEBIG UNIVERSITY   (Germany)

more..

Author keywords

Pulmonary hypertension; Survival; Systemic sclerosis; Systolic pulmonary arterial pressure; Tricuspid regurgitant jet velocity

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; SYSTOLIC PULMONARY ARTERIAL PRESSURE; TREATMENT DURATION;

EID: 84936862994     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu450     Document Type: Article

References (20)

1. Avouac J, Airò P, Meune C et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010;37:2540-7.
2. Meier F, Frommer KW, Dinser R et al. Update on the profile of the EUSTAR cohort: an analysis of the EUSTAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012;71:1355-60.
3. Hoeper MM, Bogaard HJ, Condiffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013;62(Suppl 25):D42-50.
4. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66: 940-4.
5. Tyndall AJ, Bannert B, Vonk M et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
6. Fisher MR, Mathai SC, Champion HC et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006;54: 3043-50.
7. Hachulla E, Launay D, Mouthon L et al. Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest 2009;136:1211-9.
8. Launay D, Sitbon O, Hachulla E et al. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era. Ann Rheum Dis 2013;72: 1940-6.
9. Lefevre G, Dauchet L, Hachulla E et al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and metaanalysis. Arthritis Rheum 2013;65:2412-23.
10. McLaughlin VV, Archer SL, Badesch DB et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53: 1573-619.
11. Hachulla E, de Groote P, Gressin V et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multi-center nationwide longitudinal study in France. Arthritis Rheum 2009;60: 1831-9.
12. Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multi-center study. Arthritis Rheum 2005;52:3792-800.
13. Galiè N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension'. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30: 2493-537.
14. Vachiéry JL, Coghan G. Screening for pulmonary arterial hypertension in systemic sclerosis. Eur Respir Rev 2009; 18:162-9.
15. Humbert M, Yaici A, de Groote P et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and longterm survival. Arthritis Rheum 2011;63:3522-30.
16. Kiatchoosakun S, Wongvipaporn C, Nanagara R et al. Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma. Clin Cardiol 2011;34:488-93.
17. Borgeson D, Seward J, Miller FJ et al. Frequency of Doppler measurable pulmonary artery pressures. J Am Soc Echocardiogr 1996;9:832-7.
18. Coghlan JG, Denton C, Grunig E et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014;73: 1340-9.
19. Fransen J, Popa-Diaconu D, Hesselstrand R et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis 2011;70:1788-92.
20. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-22.